Latest News in the pharma Industry

Policy & Regulation

FDA Accepts SNDA for Priority Review of Rapamune (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)

FDA Accepts SNDA for Priority Review of Rapamune (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)

23 Feb 2015

Read more 
FDA Issues New Draft Documents Related to Compounding of Human Drugs

FDA Issues New Draft Documents Related to Compounding of Human Drugs

17 Feb 2015

Read more 
FDA Approves Anticancer Agent Lenvima as Treatment for Radioactive Iodine-Refractory Dirrerentiated Thyroid Cancer

FDA Approves Anticancer Agent Lenvima as Treatment for Radioactive Iodine-Refractory Dirrerentiated Thyroid Cancer

16 Feb 2015

Read more 
SMC Recommends Bosulif for the Treatment of Chronic Myeloid Leukaemia in Scotland

SMC Recommends Bosulif for the Treatment of Chronic Myeloid Leukaemia in Scotland

11 Feb 2015

Read more 
FDA Approves Genentech’s Lucentis for Treatment of Diabetic Retinopathy in People with Diabetic Macular Edema

FDA Approves Genentech’s Lucentis for Treatment of Diabetic Retinopathy in People with Diabetic Macular Edema

9 Feb 2015

Read more 
MHRA Warns Against GcMAF Made in Unlicensed Facility in Cambridgeshire, UK

MHRA Warns Against GcMAF Made in Unlicensed Facility in Cambridgeshire, UK

6 Feb 2015

Read more 
Pfizer Announces FDA Acceptance For Review Of sNDA for Oral Xeljanz for Adult Patients With Moderate To Severe Chronic Plaque Psoriasis

Pfizer Announces FDA Acceptance For Review Of sNDA for Oral Xeljanz for Adult Patients With Moderate To Severe Chronic Plaque Psoriasis

5 Feb 2015

Read more 
Alcon Receives FDA Approval of Pazeo Solution for Ocular Allergy Itch Relief

Alcon Receives FDA Approval of Pazeo Solution for Ocular Allergy Itch Relief

2 Feb 2015

Read more 
FDA Approves Bristol-Myers Squibb’s Evotaz for the Treatment of HIV-1 Infection in Adults

FDA Approves Bristol-Myers Squibb’s Evotaz for the Treatment of HIV-1 Infection in Adults

30 Jan 2015

Read more 
Eylea Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to CRVO/BRVO

Eylea Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to CRVO/BRVO

29 Jan 2015

Read more 
Amgen Submits Applications in the US and Europe for Kyprolis (Carfilzomib) for the Treatment of Relapsed Multiple Myeloma

Amgen Submits Applications in the US and Europe for Kyprolis (Carfilzomib) for the Treatment of Relapsed Multiple Myeloma

29 Jan 2015

Read more 
Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic Sivextro

Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic Sivextro

27 Jan 2015

Read more